Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jun 10, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rapport Therapeutics, Inc.
| 3.73M |
—
|
—
|
∞
| 3.73M |
Jun 10
| |||||||
Rapport Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Boundless Bio, Inc.
| 2.63M |
$16.00 | $3,200,000.00 | +151.43% | 4.36M |
Apr 2
| |||||||
Boundless Bio, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Prime Medicine, Inc.
| 3.2M |
$6.25 | $20,000,000.00 |
∞
| 3.2M |
Feb 15
| |||||||
Sana Biotechnology, Inc.
| 1.82M |
$5.50 | $9,999,995.50 | +5.39% | 35.56M |
Feb 8
| |||||||
Neumora Therapeutics, Inc.
| 1.88M |
—
|
—
| +102.76% | 3.71M |
Dec 8
| |||||||
Neumora Therapeutics, Inc.
| 35.01K |
$11.77 | $412,139.61 | +0.85% | 4.13M |
Nov 13 - Nov 14
| |||||||
Neumora Therapeutics, Inc.
| 140.6K |
$10.98 | $1,543,563.42 | +3.55% | 4.1M |
Nov 8 - Nov 10
| |||||||
Neumora Therapeutics, Inc.
| 95.69K |
$11.49 | $1,099,944.70 | +2.48% | 3.96M |
Nov 3 - Nov 7
| |||||||
Neumora Therapeutics, Inc.
| 76.51K |
$13.68 | $1,046,848.16 | +2.02% | 3.86M |
Sep 28 - Sep 29
| |||||||
Neumora Therapeutics, Inc.
| 58.5K |
$11.97 | $700,464.24 | +1.57% | 3.78M |
Sep 26 - Sep 27
| |||||||
Neumora Therapeutics, Inc.
| 100.74K |
$11.19 | $1,127,063.95 | +2.78% | 3.72M |
Sep 22 - Sep 25
| |||||||
Neumora Therapeutics, Inc.
| 18.92M |
$17.00 |
—
| +178.19% | 29.55M |
Sep 19
| |||||||
Neumora Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Da32 Life Science Tech Acquisition Corp.
| -1.60M |
—
|
—
| -100.00% |
0
|
Jul 28
| |||||||
Vbi Vaccines Inc/bc
|
0
|
—
|
—
|
—
|
0
|
Jul 27
| |||||||
Vbi Vaccines Inc/bc
| 609.09K |
$1.65 | $1,004,998.50 | +140.28% | 1.04M |
Jul 10
| |||||||
Homology Medicines, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 14
| |||||||
Codiak Biosciences, Inc.
| 8.75K |
—
|
—
|
∞
| 8.75K |
Feb 16
| |||||||
Vbi Vaccines Inc/bc
|
0
|
—
|
—
|
—
|
0
|
Jan 26
| |||||||
Prime Medicine, Inc.
| 12.26M |
$17.00 |
—
|
∞
| 12.26M |
Oct 24
| |||||||
Prime Medicine, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Codiak Biosciences, Inc.
| 5M |
—
|
—
| +199.69% | 7.5M |
Sep 13
| |||||||
Codiak Biosciences, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 17
| |||||||
Homology Medicines, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 15
| |||||||
Codiak Biosciences, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 16
| |||||||
Vbi Vaccines Inc/bc
|
0
|
—
|
—
|
—
|
0
|
Jan 27
| |||||||
Da32 Life Science Tech Acquisition Corp.
|
0
|
—
|
—
|
—
|
0
|
Aug 5
| |||||||
Da32 Life Science Tech Acquisition Corp.
| 2.25M |
$10.00 | $22,500,000.00 | +140.63% | 3.85M |
Jul 30
| |||||||
Da32 Life Science Tech Acquisition Corp.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Erasca, Inc.
| 11.06M |
—
|
—
|
∞
| 11.06M |
Jul 20
| |||||||
Erasca, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Verve Therapeutics, Inc.
| 2.51M |
—
|
—
|
∞
| 2.51M |
Jun 21
| |||||||
Codiak Biosciences, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 18
| |||||||
Homology Medicines, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 17
| |||||||
Verve Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Sana Biotechnology, Inc.
| 43.75M |
—
|
—
| +14,957.26% | 44.04M |
Feb 8
| |||||||
Sana Biotechnology, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Vbi Vaccines Inc/bc
|
0
|
—
|
—
|
—
|
0
|
Jan 27
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.